Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of Triethylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | APP | P05067 | 3/20 | 0.34 |
| ▸ | USP2 | O75604 | 3/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pentaethylene Glycol SCHEMBL4148519 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL4140373 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| Triethylene Glycol SCHEMBL29198607 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| Tetraethylene Glycol SCHEMBL7688400 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| Hexaethylene Glycol SCHEMBL4154184 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL4143918 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL4149482 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| Pentaethylene Glycol SCHEMBL28557049 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| Tetraethylene Glycol SCHEMBL4143923 | 1.00 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL1790189 | 0.97 | TSHR (0.59) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12359332-B2 | Copper electroplating bath | Atotech Deutschland GmbH & Co. KG (DE) | 2025-07-15 | — | — | US | disclosed |
| EP-3933073-B1 | COPPER ELECTROPLATING BATH | ATOTECH DEUTSCHLAND GMBH & CO KG (DE) | 2023-11-29 | — | — | EP | disclosed |
| US-20230313401-A1 | COPPER ELECTROPLATING BATH | Atotech Deutschland GmbH & Co. KG (DE) | 2023-10-05 | — | — | US | disclosed |
| EP-4032930-B1 | BIURET-BASED QUATERNIZED POLYMERS AND THEIR USE IN METAL OR METAL ALLOY PLATING BATHS | ATOTECH DEUTSCHLAND GMBH & CO KG (DE) | 2023-08-30 | — | — | EP | disclosed |
| CN-111684111-B | Metal or metal alloy deposition compositions and electroplating compounds | 德国艾托特克公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-115735024-A | Copper electroplating bath | 德国艾托特克有限两合公司 | 2023-03-03 | — | — | CN | disclosed |
| WO-2022157292-A1 | BIURET-BASED QUATERNIZED POLYMERS AND THEIR USE IN METAL OR METAL ALLOY PLATING BATHS | Atotech Deutschland GmbH & Co. KG (DE) | 2022-07-28 | — | — | WO | disclosed |
| EP-4032930-A1 | BIURET-BASED QUATERNIZED POLYMERS AND THEIR USE IN METAL OR METAL ALLOY PLATING BATHS | Atotech Deutschland GmbH & Co. KG (DE) | 2022-07-27 | — | — | EP | disclosed |
| WO-2022002899-A1 | COPPER ELECTROPLATING BATH | ATOTECH DEUTSCHLAND GMBH (DE) | 2022-01-06 | — | — | WO | disclosed |
| EP-3933073-A1 | COPPER ELECTROPLATING BATH | ATOTECH Deutschland GmbH (DE) | 2022-01-05 | — | — | EP | disclosed |
| US-20110091533-A1 | Amphiphilic polymer capsules and related methods of interfacial assembly | NATIONAL SCIENCE FOUNDATION | 2011-04-21 | — | — | US | disclosed |
| US-7851543-B2 | Amphiphilic polymer capsules and related methods of interfacial assembly | UNIVERSITY OF MASSACHUSETTS (US) | 2010-12-14 | — | — | US | disclosed |
| US-20100036061-A1 | Amphiphilic Polymer Capsules and Related Methods of Interfacial Assembly | NATIONAL SCIENCE FOUNDATION | 2010-02-11 | — | — | US | disclosed |
| US-7598313-B2 | Amphiphilic polymer capsules and related methods of interfacial assembly | UNIVERSITY OF MASSACHUSETTS (US) | 2009-10-06 | — | — | US | disclosed |
| EP-1663469-A1 | AMPHIPHILIC POLYMER CAPSULES AND RELATED METHODS OF INTERFACIAL ASSEMBLY | The University of Massachusetts (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20050096454-A1 | Amphiphilic polymer capsules and related methods of interfacial assembly | UNIVERSITY OF MASSACHUSETTS | 2005-05-05 | — | — | US | disclosed |
| WO-2005025736-A1 | AMPHIPHILIC POLYMER CAPSULES AND RELATED METHODS OF INTERFACIAL ASSEMBLY | UNIVERSITY OF MASSACHUSETTS (US) | 2005-03-24 | — | — | WO | disclosed |
| US-4782176-A | ANTIALLERGY | HOFFMANN-LA ROCHE INC. (US) | 1988-11-01 | — | — | US | disclosed |
| US-4507498-A | Phenoxycarboxylic acids | HOFFMANN-LA ROCHE INC. (US) | 1985-03-26 | — | — | US | disclosed |
| US-4436664-A | PHASE TRANSFER AGENTS | W. R. GRACE & CO. (US) | 1984-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110091533-A1 | Amphiphilic polymer capsules and related methods of interfacial assembly | SQLE, COASY, PHOSPHO1 | MEN1 2651/4885KMT2A 4857/4885TSHR 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.